{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:27:45Z","timestamp":1786519665334,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To compare catheter directed thrombolysis (CDT) and endovascular mechanical thrombectomy (MT) for acute intermediate-risk and high-risk pulmonary embolism (PE) with respect to unplanned 6-month readmissions and in-hospital outcomes using a national database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The NRD was queried from 2016 to 2022 for adult patients with acute nonseptic PE who received either CDT or MT. Inverse probability weighted regression adjustment was used to compare CDT and MT with regard to in-hospital mortality, unplanned 6-month readmissions, discharge other than home (DOTH), total cost as well as gastrointestinal bleeding (GIB), intracranial hemorrhage (ICH), blood transfusion at index admission, and 6-month readmission. Results are depicted as average treatment effect (ATE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 28,376 patients were identified; 18,168 (64%) underwent CDT and 10,208 (36%) underwent MT. There was a total of 3,945 patients with high risk PE (13.9%). Compared to CDT, the ATE of MT was higher with regards to in-hospital mortality (ATE: 0.007;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048), DOTH (ATE: 0.031;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), ICH (ATE: 0.006;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), total cost at index admission (ATE: 0.118;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), GIB at 6\u00a0months (ATE: 0.004;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023), blood transfusions at 6\u00a0months (ATE: 0.006;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017) as well as death at final follow-up (ATE: 0.009;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025). The ATE was similar between CDT and MT with regard to GIB (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.097) at index admission as well as unplanned 6-month readmission (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.10), ICH (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.11), and recurrent PE (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.39) at 6\u00a0months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MT was associated with higher rates of mortality, DOTH, ICH, and total cost at index admission as well as GIB, blood transfusions, and mortality at 6\u00a0months. MT was associated with similar rates of GIB at index admission, as well as unplanned readmission, ICH, and recurrent PE at 6\u00a0months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42155-026-00752-1","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:32:01Z","timestamp":1786516321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unplanned 6-month readmissions and in-hospital outcomes for the management of acute intermediate- and high-risk pulmonary embolism: comparisons of endovascular interventions"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-4096","authenticated-orcid":false,"given":"Waseem","family":"Wahood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Seyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"752_CR1","unstructured":"B\u0115lohl\u00e1vek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18:129\u201338. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23940438."},{"key":"752_CR2","doi-asserted-by":"publisher","unstructured":"Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J, Harjola V-P, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41:543\u2013603. Available from: https:\/\/doi.org\/10.1093\/eurheartj\/ehz405.","DOI":"10.1093\/eurheartj\/ehz405"},{"key":"752_CR3","doi-asserted-by":"crossref","unstructured":"Toma C, Bunte MC, Cho KH, Jaber WA, Chambers J, Stegman B, et al. Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: interim results of the FLASH registry. Catheter Cardiovasc Interv. 2022;99:1345\u201355. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ccd.30091.","DOI":"10.1002\/ccd.30091"},{"key":"752_CR4","doi-asserted-by":"publisher","unstructured":"Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370:1402\u201311. Available from: https:\/\/doi.org\/10.1056\/NEJMoa1302097.","DOI":"10.1056\/NEJMoa1302097"},{"key":"752_CR5","doi-asserted-by":"publisher","unstructured":"Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36:605\u201314. Available from: https:\/\/doi.org\/10.1093\/eurheartj\/ehu218.","DOI":"10.1093\/eurheartj\/ehu218"},{"key":"752_CR6","doi-asserted-by":"publisher","unstructured":"Desai KR. Mechanical Thrombectomy in Pulmonary Embolism. JACC: Cardiovascular Interventions. 2021. p. 330\u20132. Available from: https:\/\/doi.org\/10.1016\/j.jcin.2020.11.002.","DOI":"10.1016\/j.jcin.2020.11.002"},{"key":"752_CR7","doi-asserted-by":"publisher","unstructured":"Jaber WA, Gonsalves CF, Stortecky S, Horr S, Pappas O, Gandhi RT, et al. Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial. Circulation. 2024. Available from: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.072364.","DOI":"10.1161\/CIRCULATIONAHA.124.072364"},{"key":"752_CR8","doi-asserted-by":"publisher","unstructured":"Inci EK, Khandhar S, Toma C, Licitra G, Brown MJ, Herzig M, et al. Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: a multicenter experience. Catheter Cardiovasc Interv. 2023;101:140\u20136. Available from: https:\/\/doi.org\/10.1002\/ccd.30505.","DOI":"10.1002\/ccd.30505"},{"key":"752_CR9","doi-asserted-by":"publisher","unstructured":"Graif A, Patel KD, Wimmer NJ, Kimbiris G, Grilli CJ, Upparapalli D, et al. Large-bore aspiration thrombectomy versus catheter-directed thrombolysis for acute pulmonary embolism: a propensity score-matched comparison. J Vasc Interv Radiol. 2020;31:2052\u20139. Available from: https:\/\/doi.org\/10.1016\/j.jvir.2020.08.028.","DOI":"10.1016\/j.jvir.2020.08.028"},{"key":"752_CR10","doi-asserted-by":"publisher","unstructured":"Tran A, Toma C, Jaber W, Heintz J, Matthai WH, Palevsky H, et al. Cost-comparison of mechanical thrombectomy and catheter-directed thrombolysis in intermediate-risk pulmonary embolism. J Soc Cardiovasc Angiogr Interv. 2024;3:101187. Available from: https:\/\/doi.org\/10.1016\/j.jscai.2023.101187.","DOI":"10.1016\/j.jscai.2023.101187"},{"key":"752_CR11","doi-asserted-by":"publisher","unstructured":"Abrahamian A, Khokher W, Ahmad R, Holtzapple Z, Patel R, Assaly RA, et al. Catheter-directed thrombolysis vs mechanical thrombectomy in treatment of acute pulmonary embolism: a systemic review and meta-analysis of dual arm studies. Chest. 2023;164:A5245\u20136. Available from: https:\/\/doi.org\/10.1016\/j.chest.2023.07.3401.","DOI":"10.1016\/j.chest.2023.07.3401"},{"key":"752_CR12","doi-asserted-by":"publisher","unstructured":"Rosenfield K, Klok FA, Piazza G, Sharp ASP, N\u00ed \u00c1inle F, Jaff MR, et al. Ultrasound-facilitated, catheter-directed fibrinolysis for acute pulmonary embolism. N Engl J Med. 2026. Available from: https:\/\/doi.org\/10.1056\/NEJMoa2516567.","DOI":"10.1056\/NEJMoa2516567"},{"key":"752_CR13","unstructured":"NRD Database Documentation. Available from: https:\/\/hcup-us.ahrq.gov\/db\/nation\/nrd\/nrddbdocumentation.jsp.\u00a0Cited 2 Mar 2023."},{"key":"752_CR14","doi-asserted-by":"publisher","unstructured":"Smith SB, Geske JB, Kathuria P, Cuttica M, Schimmel DR, Courtney DM, et al. Analysis of national trends in admissions for pulmonary embolism. Chest. 2016;150:35\u201345. Available from: https:\/\/doi.org\/10.1016\/j.chest.2016.02.638.","DOI":"10.1016\/j.chest.2016.02.638"},{"key":"752_CR15","doi-asserted-by":"publisher","unstructured":"Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation. 2005;112:e28\u201332. Available from: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.551374.","DOI":"10.1161\/CIRCULATIONAHA.105.551374"},{"key":"752_CR16","doi-asserted-by":"publisher","unstructured":"Yamamoto T. Management of patients with high-risk pulmonary embolism: a narrative review. J Intensive Care Med. 2018;6:16. Available from: https:\/\/doi.org\/10.1186\/s40560-018-0286-8.","DOI":"10.1186\/s40560-018-0286-8"},{"key":"752_CR17","doi-asserted-by":"crossref","unstructured":"Wahood W, Sista AK, Paul JD, Ahmed O. Unplanned 30-day readmissions after management of submassive and massive acute pulmonary embolism: catheter-directed versus systemic thrombolysis. J Vasc Interv Radiol. 2023;34. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36167297\/.\u00a0Cited 16 Feb 2023.","DOI":"10.1016\/j.jvir.2022.09.017"},{"key":"752_CR18","doi-asserted-by":"publisher","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47:626\u201333. Available from: https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5.","DOI":"10.1097\/MLR.0b013e31819432e5"},{"key":"752_CR19","doi-asserted-by":"publisher","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399\u2013424. Available from: https:\/\/doi.org\/10.1080\/00273171.2011.568786.","DOI":"10.1080\/00273171.2011.568786"},{"key":"752_CR20","doi-asserted-by":"publisher","unstructured":"Witte J, Didelez V. Covariate selection strategies for causal inference: classification and comparison. Biom J. 2019;61:1270\u201389. Available from: https:\/\/doi.org\/10.1002\/bimj.201700294.","DOI":"10.1002\/bimj.201700294"},{"key":"752_CR21","doi-asserted-by":"publisher","unstructured":"Tu T, Toma C, Tapson VF, Adams C, Jaber WA, Silver M, et al. A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv. 2019;12:859\u201369. Available from: https:\/\/doi.org\/10.1016\/j.jcin.2018.12.022.","DOI":"10.1016\/j.jcin.2018.12.022"},{"key":"752_CR22","doi-asserted-by":"publisher","unstructured":"Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv. 2015;8:1382\u201392. Available from: https:\/\/doi.org\/10.1016\/j.jcin.2015.04.020.","DOI":"10.1016\/j.jcin.2015.04.020"},{"key":"752_CR23","doi-asserted-by":"publisher","unstructured":"Sista AK, Horowitz JM, Tapson VF, Rosenberg M, Elder MD, Schiro BJ, et al. Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial. JACC Cardiovasc Interv. 2021;14:319\u201329. Available from: https:\/\/doi.org\/10.1016\/j.jcin.2020.09.053.","DOI":"10.1016\/j.jcin.2020.09.053"},{"key":"752_CR24","doi-asserted-by":"publisher","unstructured":"Monteleone PP. Acute safety of contemporary pulmonary embolism treatment with ultrasoundassisted catheter-directed thrombolysis or mechanical thrombectomy in a large matched sample: real-PE ii. J Am Coll Cardiol. 2025;85:2166. Available from: https:\/\/doi.org\/10.1016\/s0735-1097(25)02650-6.","DOI":"10.1016\/s0735-1097(25)02650-6"},{"key":"752_CR25","doi-asserted-by":"publisher","unstructured":"Monteleone P, Ahern R, Banerjee S, Desai KR, Kadian-Dodov D, Webber E, et al. Modern treatment of pulmonary embolism (USCDT vs MT): results from a real-world, big data analysis (REAL-PE). J Soc Cardiovasc Angiogr Interv. 2024;3:101192. Available from: https:\/\/doi.org\/10.1016\/j.jscai.2023.101192.","DOI":"10.1016\/j.jscai.2023.101192"},{"key":"752_CR26","doi-asserted-by":"publisher","unstructured":"Monteleone P, Banerjee S, Desai KR, Jaff MR. Stop apologizing for real-world data. Am J Cardiol. 2024;211:374\u20136. Available from: https:\/\/doi.org\/10.1016\/j.amjcard.2023.10.033.","DOI":"10.1016\/j.amjcard.2023.10.033"},{"key":"752_CR27","doi-asserted-by":"publisher","unstructured":"Majmundar M, Majmundar V, Bhat V, Patel KN, Parmar G, Alli A, et al. Endovascular mechanical thrombectomy versus catheter-directed thrombolysis in pulmonary embolism: insights from the National Readmission Database. Eur Heart J Acute Cardiovasc Care. 2025. Available from: https:\/\/doi.org\/10.1093\/ehjacc\/zuaf110.","DOI":"10.1093\/ehjacc\/zuaf110"},{"key":"752_CR28","volume-title":"Causal inference: what if","author":"A Miguel","year":"2023","unstructured":"Miguel A, Robins HERNAN(JAMESM). Causal inference: what if. CRC PRESS; 2023."},{"key":"752_CR29","doi-asserted-by":"crossref","unstructured":"Arora S, Panaich SS, Ainani N, Kumar V, Patel NJ, Tripathi B, et al. Comparison of in-hospital outcomes and readmission rates in acute pulmonary embolism between systemic and catheter-directed thrombolysis (from the National Readmission Database). Am J Cardiol. 2017;120:1653\u201361. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002914917312390.","DOI":"10.1016\/j.amjcard.2017.07.066"},{"key":"752_CR30","doi-asserted-by":"publisher","unstructured":"Rabinstein AA. Administrative medical databases for clinical research: the good, the bad, and the ugly. Neurocrit Care. 2018;29:323\u20135. Available from: https:\/\/doi.org\/10.1007\/s12028-018-0625-6.","DOI":"10.1007\/s12028-018-0625-6"},{"key":"752_CR31","unstructured":"Reimbursement. Inari Medical. 2021. Available from: https:\/\/www.inarimedical.com\/reimbursement\/.\u00a0Cited 27 Apr 2023."},{"key":"752_CR32","doi-asserted-by":"publisher","unstructured":"Beyer SE, Shanafelt C, Pinto DS, Weinstein JL, Aronow HD, Weinberg I, et al. Utilization and outcomes of thrombolytic therapy for acute pulmonary embolism: a nationwide cohort study. Chest. 2020;157:645\u201353. Available from: https:\/\/doi.org\/10.1016\/j.chest.2019.10.049.","DOI":"10.1016\/j.chest.2019.10.049"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00752-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-026-00752-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00752-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:32:04Z","timestamp":1786516324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-026-00752-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s42155-026-00752-1","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript reports on de-identified patient data that is publicly available for purchase. Institutional review board approval was not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"99"}}